Cargando…
SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells
Increasing evidence suggests incomplete recovery of COVID-19 patients, who continue to suffer from cardiovascular diseases, including cerebral vascular disorders (CVD) and neurological symptoms. Recent findings indicate that some of the damaging effects of severe acute respiratory syndrome coronavir...
Autores principales: | Choi, Ji-Young, Park, Jung Hyun, Jo, Chulman, Kim, Kyung-Chang, Koh, Young Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349051/ https://www.ncbi.nlm.nih.gov/pubmed/35970046 http://dx.doi.org/10.1016/j.bbrc.2022.07.113 |
Ejemplares similares
-
BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2012) -
BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2013) -
The beta secretase BACE1 regulates the expression of insulin receptor in the liver
por: Meakin, Paul J., et al.
Publicado: (2018) -
The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007) -
Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer's disease
por: Vakilian, Alireza, et al.
Publicado: (2019)